Showing results (21-30 of 98) with videos related to
Sort By:
Pageof 10
Annales D'Endocrinologie|March 18, 2020
Monitoring patients receiving dopamine agonist therapy for hyperprolactinaemiaC E Stiles, R P Steeds, W M DrakeClinical Therapeutics|May 17, 2001
Consensus statement on the modern therapy of Paget's disease of bone from a Western Osteoporosis Alliance symposium. Biannual Foothills Meeting on Osteoporosis, Calgary, Alberta, Canada, September 9-10, 2000W M Drake, D L Kendler, J P BrownEuropean Journal of Endocrinology|August 19, 2008
Clinical use of cabergoline as primary and adjunctive treatment for acromegalyV J Moyes, K A Metcalfe, W M DrakeJournal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|January 4, 2003
Hadju-Cheney syndrome: response to therapy with bisphosphonates in two patientsW M Drake, M P Hiorns, D L KendlerInternational Journal of Cardiology|January 1, 1993
Prothrombin fragment F1 + 2 concentrations for monitoring anticoagulation therapy with heparinM J Brack, R S More, P J Hubner, et al.Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|February 1, 1993
The effect of low dose nitroglycerin on plasma heparin concentrations and activated partial thromboplastin timesM J Brack, R S More, P J Hubner, et al.Postgraduate Medical Journal|February 1, 1994
The effect of different nitrate preparations on plasma heparin concentrations and the activated partial thromboplastin timeM J Brack, R S More, P J Hubner, et al.Cardiovascular Research|December 1, 1993
Effect of locally applied tissue-type plasminogen activator on venous fibrinolytic activity: in vitro and in vivo investigationsM J Underwood, R S More, A H Gershlick, et al.Coronary Artery Disease|January 1, 1993
Angiographic restenosis after angioplasty: comparison of definitions and correlation with clinical outcomeA Gershlick, M J Brack, R S More, et al.Trends in Endocrinology and Metabolism: TEM|October 12, 2001
Clinical use of a growth hormone receptor antagonist in the treatment of acromegalyW M Drake, C Parkinson, G M Besser, et al.Pageof 10